HomeNewsTrendsEntertainmentIndia's ad spends to grow over 10% to reach $9 billion this year: Report

India's ad spends to grow over 10% to reach $9 billion this year: Report

According to the report, TV continues to be the most popular media in India, with a leading 40.9 percent share of spend that shows resilience despite the pandemic and a 7.7 percent growth compared to 2020 spend.

July 13, 2021 / 21:08 IST
Story continues below Advertisement
Regional live events such as Tokyo Olympics and Paralympics Games continue to be a significant driver of growth in TV ad spend in APAC, which is expected to increase 3.9 percent in 2021 to reach $59.2 billion.
Regional live events such as Tokyo Olympics and Paralympics Games continue to be a significant driver of growth in TV ad spend in APAC, which is expected to increase 3.9 percent in 2021 to reach $59.2 billion.

India's advertising spend is estimated to grow 10.8 percent this year to reach $9 billion, following a steep 12.9 percent decline in 2020, according to a report by Dentsu, a digital marketing communications company.

According to the report, TV continues to be the most popular media in India, with a leading 40.9 percent share of spend that shows resilience despite the pandemic and a 7.7 percent growth compared to 2020 spends.

Story continues below Advertisement

Digital’s share of spend has grown rapidly, from 20 percent in 2019 to 29.4 percent in 2021, and is expected to reach 32.7 percent by the end of 2022.

The country's ad market is expected to grow by a further 12.4 percent in 2022, recovering to pre-pandemic levels, particularly led by digital and TV. As for other mediums, print, cinema, out of home (OOH) and radio will see a longer recovery period.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show